BioNTech-Pfizer confident about their vaccine for kids

biontech pfizer confident about their vaccine for kids

Sumary of BioNTech-Pfizer confident about their vaccine for kids:

  • And indeed, back in May, the German half of the BioNTech-Pfizer COVID-19 vaccine team announced it was aiming to submit applications for emergency use authorizations in the US and the European Union for children aged 2 to 5 years and those aged 5-11 years by September.
  • But fortunately for BioNTech-Pfizer — the joint-effort vaccine now known as Comirnaty or just Pfizer — their side of the plans appear to be on track.
  • In an interview published by German weekly Der Spiegel on Friday, BioNTech’s co-founder and chief medical officer, Özlem Türeci, is reported as saying that the firm is already preparing production of the vaccine for children — ahead of approval.
  • Türeci told the magazine, “It’s the same vaccine but a lower dose.
  • ” Children and COVID vaccines It’s generally thought that COVID vaccines produce the same side effects in children as they do in adults.
  • ” COVID vaccines are considered “reactogenic” — they are expected to produce strong physical reactions.
  • Early trials ‘inadequate’ Drug regulators have pressed for special clinical trials of COVID vaccines in children.
  • In the US, for instance, the FDA demanded BioNTech-Pfizer and their competitor, Moderna, which produces Spikevax, conduct broader trials — that was also back in May.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.